Evaluating the Efficacy of Artificial Intelligence Models in Predicting Intensive Care Unit Admission Needs

NCT ID: NCT06494748

Last Updated: 2024-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8043 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-15

Study Completion Date

2024-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the efficacy of two artificial intelligence (AI) models in predicting the need for ICU admissions. By comparing the AI models' predictions with actual clinical decisions, we aim to determine their accuracy and potential utility in clinical decision support.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intensive care units (ICUs) are critical components of healthcare systems, providing life-saving care to patients with severe and life-threatening conditions. Timely and accurate prediction of ICU admission needs is essential for improving patient outcomes and optimizing hospital resource allocation. Delayed ICU admissions have been consistently associated with higher morbidity and mortality rates. With the advent of artificial intelligence (AI) in healthcare, there is an opportunity to enhance clinical decision-making by leveraging AI models to predict ICU needs accurately. AI models, such as ChatGPT and Gemini, can process vast amounts of complex data to identify patterns that might not be immediately evident to human clinicians, potentially improving the speed and accuracy of ICU admission decisions.

This is an observational retrospective study. Data were collected from electronic health records (EHRs) from a hospital retrospectively.

Data were extracted from EHRs and included:

Demographic data: Age, gender, and basic patient characteristics. Clinical parameters: Medication information, consultation details, ECG findings, imaging results, comorbid conditions (e.g., diabetes mellitus, hypertension, heart failure, COPD, cerebrovascular events), and laboratory values (e.g., hemoglobin, hematocrit, platelet count, PT, INR, procalcitonin, ALT, AST, bilirubin, sodium, potassium, chloride, glucose, creatinine, urea, albumin, thyroid function tests).

Prediction data: AI model predictions and actual ICU admission decisions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intensive Care Unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anesthesiologists Decision

Intensive Care Unit Follow up need is decided by anesthesiologists.

Follow up Decision

Intervention Type OTHER

0: No need to follow up in Intensive Care Unit

1: Need to follow up in Intensive Care Unit

Artificial Intelligence Decision

Intensive Care Unit Follow up need is decided by Artificial Intelligence

Follow up Decision

Intervention Type OTHER

0: No need to follow up in Intensive Care Unit

1: Need to follow up in Intensive Care Unit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Follow up Decision

0: No need to follow up in Intensive Care Unit

1: Need to follow up in Intensive Care Unit

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over the age of 18
* Patients consulted for anesthesia regarding intensive care needs
* Patients with sufficient data in the hospital's electronic health record system

Exclusion Criteria

* Patients with insufficient data in the hospital records
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Engin Ihsan Turan

anesthesiology and reanimation specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Engin ihsan Turan, Specialist

Role: PRINCIPAL_INVESTIGATOR

Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ICU-retro

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.